The Food and Drug Administration of the US has revised their sunscreen monograph. This monograph regulates all sunscreen products available in the United States market. The Proposed Amendment of Final Monograph was recently released by the FDA. This shows the progress made by the agency in giving guidance to sunscreen manufacturers on the types of products marketed in the US.

Highlights of the new sunscreen monograph
a. This monograph lists the active sunscreen ingredients like ultraviolet filters that are permitted for use in the United States, the chemicals used, their concentration and combinations of sun-protective chemicals.
b. The FDA will now specify how manufacturers can test for SPF (sun protection factor) as well as the ultraviolet A (UVA) protection factors offered by sunscreens.
c. The FDA proposed to increase the cap of ultraviolet B (UVB) SPF to 50+.
d. It has also proposed a four-star UVA protection rating system based on in vivo and in vitro testing methods.
e. There is a 90-day commentary period for the new monograph.
f. After this period, the FDA will respond to comments from the industry.
g. Then a final ruling will be given.
h. Once the final ruling is released, manufacturers will have 18 months to comply.
i. FDA guidelines must be followed by manufacturers of any type of sunscreen product marketed in the United States.